ArticleAnimal bioscience2026
ACSS2 governs milk fat synthesis in buffalo via a reciprocal positive feedback loop with SREBP1 and PPARG.
Article in Animal bioscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
objectiveAcetyl-CoA synthetase 2 (ACSS2) converts rumen-derived acetate into acetyl-CoA in ruminants. Whether it actively regulates lactation-associated transcriptional networks beyond its catalytic role remains unclear. This study aimed to characterize buffalo ACSS2 and investigate its function within the metabolic-transcriptional network of buffalo mammary epithelial cells (BuMECs).
methodsThe buffalo ACSS2 coding sequence was cloned, and its expression across lactation stages was analyzed. Subcellular localization was determined via confocal microscopy. Through siRNA-mediated knockdown in BuMECs, we assessed cell viability, triglyceride (TAG) content, and the expression of core metabolic and regulatory genes.
resultsACSS2 expression was highly enriched in lactating mammary tissue, and the protein localized to both the nucleus and cytoplasm. In BuMECs, ACSS2 knockdown impaired lipogenesis, significantly reducing intracellular TAG and downregulating key lipid metabolism genes (FASN, ACACA, SCD, CD36, LPL, FABP3, DGAT1, DGAT2, and AGPAT6). It also inhibited cell proliferation and downregulated G1/S phase regulators (CCND1, CCNE1, CDK2, and CDK4). Mechanistically, ACSS2 depletion reduced the mRNA levels of master regulators SREBF1 and PPARG, while upregulating the SREBP1-inhibitor INSIG1, suggesting an INSIG1-mediated blockade of the lipogenic program.
conclusionThis study establishes ACSS2 as a critical metabolic checkpoint in the buffalo mammary gland. We propose that ACSS2 maintains a reciprocal positive feedback loop with SREBP1 and PPARG. By ensuring adequate acetyl-CoA to suppress INSIG1 and support nuclear histone acetylation, ACSS2 couples substrate availability to the stability of the lipogenic program and cell cycle progression. These findings reveal a conserved metabolic-epigenetic axis essential for high-efficiency lactation in ruminants.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.